Abstract
ABSTRACT: The objective of this study was to present a perspective for the management of patients in the managed care environment with amyotrophic lateral sclerosis (ALS) parallel to that for patients with neoplasms, highlighting the potential contributions of the pharmacist. This article presents a brief overview of ALS and illustrates a therapeutic parallel to the management of patients with cancer. Physicians often are reluctant to prescribe riluzole because it is not a cure for ALS. Oncologists, however, commonly initiate antineoplastic regimens with limited efficacy in their patients because such action allows the patient hope for alleviation of symptoms and an extended life expectancy. A similar approach to treating patients with ALS presents professional opportunities for the managed care pharmacist. Such management of patients with ALS, if approached like that of patients with cancer, would enhance their quality of life and life expectancy. Treatment should be initiated early in the course of ALS,...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
